Krystal Biotech buy Chardan Capital
Start price
25.07.25
/
50%
€125.75
Target price
25.07.26
€186.52
Performance (%)
-1.71%
Price
19.08.25
€123.60
Summary
This prediction is currently active. With a performance of -1.71%, the BUY prediction for Krystal Biotech by Chardan_Capital is down slightly. This prediction currently runs until 25.07.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Krystal Biotech | 0.447% |
| iShares Core DAX® | 0.855% |
| iShares Nasdaq 100 | -1.591% |
| iShares Nikkei 225® | 0.299% |
| iShares S&P 500 | -0.197% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
-28.24%
19.08.25
19.08.25
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
-18.63%
19.08.25
19.08.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
-25.47%
19.08.25
19.08.25